Neutrophil activation in acute human central nervous system injury

Neurological Research

Volumn 19, Issue 6, 1997, Pages 588-592

  Bednar, Martin M ^a,b   Gross, Cordell E ^a   Howard, Diantha B ^b   Lynn, Mary ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Central nervous system injury; Chemiluminescence; Neutrophil; Stroke; Subarachnoid hemorrhage; Trauma

Indexed keywords

LUMINOL;

ADULT; AGED; ARTICLE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; FEMALE; HEAD INJURY; HUMAN; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; SPINAL CORD INJURY; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 0031454179     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740864     Document Type: Article

References (6)

1. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Croup. NEJM 1995; 333: 1581-1587
2. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn HR. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med 1990; 322: 1405-1411
3. Bowes MP, Rothlein R, Fagan SC, Zivin JA. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 1995; 45: 815-819
4. Chen H, Chopp M, Zhang RL, Bodzin G, Chen Q, Rusche JR, Todd RF. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Annals Neurology 1994; 35: 458-463
5. Bednar MM, Raymond S, McAuliffe T, Lodge PA, Gross CE. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke 1991; 22: 44-50
6. Bednar MM, Kohut JJ, Kimelberg HK, Gross JJ, Gross CE. In vitro evidence supporting two mechanisms of action for the anion transport inhibitor L-644,711 in cerebral ischaemia. Neurol Res 1992; 14: 53-56